SIRO Clinpharm Provides Update on Integration of its European Acquisition

Announces renaming of Omega Mediation Group companies as SIRO Clinpharm

MUMBAI, India, January 11 - In April 2008 SIRO Clinpharm, a global Contract Research Organization
(CRO) with bases in India, US, Europe and Israel, had acquired Omega
Mediation Group which now spearheads its European operations.

SIRO today announced that Omega Mediation Group companies in Germany,
Greece, Romania, Estonia and Israel have now been renamed as SIRO Clinpharm.
As part of SIRO's Omega integration agenda, the legal change of the company
name is a progressive post acquisition step taken by SIRO to establish a
common identity across the group and a consistent interface to clients.

"The acquisition, besides opening up wider geographies for our clients,
has brought together a vast pool of talented resources which will ensure
consistent delivery of our best capabilities to them," said Scott Spector,
President, Europe.

"With the official name change now complete we are glad to take charge of
the baton from Volker and Sofia Hofmann, who started and headed Omega
Mediation and supported us throughout the integration process over a period
of more than 20 months. This acquisition has been synergistic; having brought
together business strengths and organizational values of both SIRO and Omega.
It has been going great and we have huge expectations with strategies mapped
out to ensure that we expand in Europe further and grow as aggressively as we
have been," said Chetan Tamhankar, Chief Executive Officer.

Earlier during 2009 SIRO opened new offices in Czech Republic and Spain.

During 2009, SIRO formed significant alliances with CambReg, U.K., a
European Regulatory services provider, Mediscis, a French Early Phase
specialist Clinical Research Organization, and a world class logistics
company to support SIRO's Clinical Trials Supplies business.

In late 2009, SIRO joined hands with a Site Management Organization in
Sri Lanka to broaden its services in the South East Asian region.

SIRO has a rich experience servicing top global pharmacy and biotech
clients for more than a decade since its inception.

About SIRO:

SIRO Clinpharm Private Limited (SIRO) is among one of the leading global
Clinical Research Organizations (CROs), offering full scope services,
conducting clinical trials in the Pharmaceutical, Biotechnology and Medical
Devices sectors in compliance with International Standards. SIRO is one of
the first CROs founded in India, which caters to the needs of pharmaceutical
companies across the world. The company has offices in India, USA, Israel and
in Europe in Germany, Romania, Estonia, Greece, Czech Republic and Spain. For
more information please visit - www.siroclinpharm.com.

Aniruddh Patwardhan, Head - Corporate Marketing SIRO Clinpharm Pvt.Ltd., +91-22-2584-8099, aniruddh.patwardhan at siroclinpharm.com